Home › Myoclonic Epilepsies › Texas
Myoclonic Epilepsies clinical trials in Texas
4 studies for Myoclonic Epilepsies are looking for participants at sites in Texas.
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Cook Children's Medical Center, Fort Worth
RecruitingPhase 1/2
6 Months – 17 Years · All sexes · Updated Sep 22, 2026 · NCT05419492A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Child Neurology Consultants of Austin, Austin
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Sep 15, 2026 · NCT04462770The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
- The University of Texas Health Science Center at Houston, Houston
RecruitingPhase 4
Ages 16 and older · All sexes · Updated Jul 15, 2026 · NCT07112365GABA Biomarkers in Dravet Syndrome
- Cook Children's Medical Center, Fort Worth
RecruitingObservational studyHealthy volunteers welcome
Up to age 18 · All sexes · Updated Dec 14, 2022 · NCT05651204From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.